Dr. Lu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3181 SW Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-494-8530Fax+1 503-494-8513
Education & Training
Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 2015 - 2018
University of California, Davis, School of MedicineClass of 2015
Certifications & Licensure
CA State Medical License 2019 - 2025
OR State Medical License 2018 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society
Publications & Presentations
PubMed
- 191 citationsAnalysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of BRCA2 Reversion Mutations Associated with Resistance to PARP Inhibitors.David A. Quigley, Joshi J. Alumkal, Alexander W. Wyatt, Vishal Kothari, Adam Foye
Cancer Discovery. 2017-09-01 - 9 citationsCopy number loss of 17q22 is associated with enzalutamide resistance and poor prognosis in metastatic castration-resistant prostate cancerXiangnan Guan, Duanchen Sun, Eric Lu, Joshua Urrutia, Robert E. Reiter
Clinical Cancer Research. 2020-09-01 - 82 citationsTranscriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistanceJoshi J. Alumkal, Duanchen Sun, Eric Lu, Tomasz M. Beer, George Thomas
Proceedings of the National Academy of Sciences of the United States of America. 2020-06-02
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
